Preliminary evidence that incorporation of 5-fluorouracil into RNA correlates with antitumor response

Cancer Invest. 1992;10(4):265-9. doi: 10.3109/07357909209032750.

Abstract

A comparative study of two different species of a fluorouracil assay was conducted on 11 patients who had carcinoma that was deemed unresectable after the surgical operation. For these patients FU at a dose of 10 mg/kg was intravenously administered before operation, and portions of the tumors were resected within 120-150 min to assay both the (FU)RNA/RNA and FU/protein. After surgery, all patients were given FU alone either intravenously or orally. The FU, which was in an acid-soluble material (FU/protein), was not related to the antitumor effect of FU. However, the FU in RNA [(FU)RNA/RNA)] was found to be related to the antitumor effect of FU. When the concentration of (FU)RNA/RNA was above approximately 200 ng/mg, FU was effectual in unresectable carcinomas. It is probable that the (FU)RNA/RNA may be more suitable than FU/protein for predicting the antitumor effect of FU.

Publication types

  • Comparative Study

MeSH terms

  • Colonic Neoplasms / drug therapy
  • Colonic Neoplasms / metabolism*
  • Fluorodeoxyuridylate / metabolism*
  • Fluorouracil / metabolism*
  • Fluorouracil / therapeutic use
  • Humans
  • Liver Neoplasms / drug therapy
  • Liver Neoplasms / metabolism*
  • RNA, Neoplasm / metabolism*
  • Rectal Neoplasms / drug therapy
  • Rectal Neoplasms / metabolism*
  • Remission Induction
  • Stomach Neoplasms / drug therapy
  • Stomach Neoplasms / metabolism*

Substances

  • RNA, Neoplasm
  • Fluorodeoxyuridylate
  • Fluorouracil